查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529773

心臟移植治疗市场规模、份额、趋势分析报告：按药物类型、通路、地区、细分市场预测，2024-2030 年

Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

市场规模及趋势

2023年全球心臟移植治疗市场规模预估为10.8亿美元，预估2024年至2030年复合年增长率为4.25%。心臟衰竭、冠状动脉疾病和心肌病等心血管疾病（CVD）盛行率的增加是这一增长的主要驱动力。例如，根据 PCR Online 的数据，CVD 仍然是全世界男性和女性死亡的主要原因。截至2023年，世界人口为80亿，约6.2亿人患有心臟病和循环系统疾病。全球每年约有 6000 万人患有心臟病和循环系统疾病。

此外，肥厚型心肌病（HCM）盛行率的增加是促进心臟移植治疗市场成长的关键因素之一。肥厚型心肌病被认为是世界上最常见的遗传性心肌病。据克利夫兰诊所称，全球 HCM 盛行率估计约为每 500 人中就有 1 人患有 HCM。这种疾病可导致各种併发症，如心律不整、心臟衰竭和心臟猝死。除肥厚型心肌病外，其他遗传性心肌病也对市场成长产生有效影响。这些包括扩张型心肌病、限制性心肌病和致心律不整性右心室心肌病。扩张型心肌病比 HCM 更常见，大约每 2,000 至 2,500 人中就有 1 人患有扩张型心肌病变。

为了意识提升，同意死后器官捐赠的人数不断增加。例如，2023 年 5 月，卫生部长史蒂芬唐纳利发起了“2023 年器官捐赠意识週”，重点关注爱尔兰器官捐赠和移植服务的进展。部长在演讲中表示，器官捐赠系统已从 COVID-19 的影响中恢復过来，并取得了令人印象深刻的开局，去年进行了 250 例移植手术，2023 年第一季进行了81 例移植手术。我强调，我把它剪掉了。部长感谢参与此过程的所有人，包括移植中心、重症监护室工作人员、器官捐赠护理经理以及爱尔兰器官捐赠和移植协会。这缓解了可用于移植的供体心臟的短缺，并支持了心臟移植治疗市场的成长。

此外，全球老年人口的增加是显着推动市场成长的通用因素。可能需要心臟移植的与老龄化相关的心血管疾病的盛行率正在增加。根据国家健康统计中心的数据，2020年，美国18岁以上成年人中有6.3%被诊断出患有心臟病。

2023 年，健康指标与评估研究所对 1990 年至 2022 年全球心血管疾病负担与风险的研究揭示了重要的见解。

  • 年龄标准化心血管疾病 (CVD) 死亡率因地区而异，到 2022 年，亚太地区高所得者的年龄标准化心血管疾病(CVD) 死亡率为每10 万人73.6 人，东欧每10 万人432.3 人。
  • 1990年至2022年，全球CVD死亡率显着下降34.9%。
  • 伤残调整生命年 (DALY) 的主要原因：缺血性心臟疾病已成为全球伤残调整生命年 (DALY) 的主要原因，年龄标准化 DALY 为每 10 万人 2,275.9 个。在年龄标准化伤残调整生命年 (DALY) 中，脑出血和缺血性中风是 CVD 的重要原因。
  • 年龄标准化 CVD 盛行率：全世界盛行率各不相同，从南亚每 10 万人 5,881.0 人到中亚每 10 万人 11,342.6 人。
  • 主要危险因子：高收缩压是造成年龄标准化 CVD DALY 人数最多的原因，全球整体每 10 万人中有 2,564.9 人患有高收缩压。
  • 风险因子的显着变化（1990-2022）：固态燃料家庭空气污染变化最大，归因年龄标准化伤残调整生命年下降了 65.1%。

旨在提高器官捐赠率、津贴移植医学研究以及简化器官移植监管流程的政府措施也有助于推动心臟移植治疗市场的发展。 2024 年 1 月，国际心肺移植学会 (ISHLT) 宣布已拨款超过 40 万美元资金支持研究工作。它旨在加强对晚期心臟病和肺病患者的护理。这些津贴是透过 ISHLT 基金会的财政支持实现的。值得注意的是，这些津贴将为 2023 年 ISHLT津贴週期的第二轮提供资金。

心臟移植治疗全球市场细分报告

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据药物类型、分销管道和地区对全球心臟移植治疗市场报告进行了细分。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章心臟移植治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 心臟移植治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章心臟移植治疗市场：药物类型、估计与趋势分析

  • 细分仪表板
  • 心臟移植治疗市场：药物种类波动分析
  • 按药物类型分類的心臟移植治疗市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 免疫抑制剂
  • 抗感染
  • 止痛药
  • 其他的

第五章心臟移植治疗市场：通路、估计与趋势分析

  • 细分仪表板
  • 心臟移植治疗市场：通路波动分析
  • 按分销管道分類的心臟移植治疗市场展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院药房
  • 零售药房
  • 网路药房

第六章心臟移植治疗市场：区域估计与趋势分析

  • 区域仪表板
  • 区域心臟移植治疗市场波动分析
  • 心臟移植治疗市场：按技术和最终用途的区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 2018-2030年北美心臟移植治疗市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 2018-2030年欧洲心臟移植治疗市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太心臟移植治疗市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲心臟移植治疗市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲心臟移植治疗市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Astellas Pharma Inc.
    • Biocon Ltd.
    • Dr Reddys Laboratories Ltd.
    • Endo International Plc
    • GlaxoSmithKline Plc
    • Glenmark Pharmaceuticals Ltd.
    • Intas Pharmaceuticals Ltd.
    • Jubilant Pharmova Ltd.
    • LEO Pharma AS
    • Lupin Ltd.
Product Code: GVR-4-68040-349-2

Market Size & Trends

The global heart transplantation therapeutics market size was estimated at USD 1.08 billion in 2023 and is anticipated to grow at a CAGR of 4.25% from 2024 to 2030. The rising incidence of cardiovascular diseases (CVDs), such as heart failure, coronary artery disease, and cardiomyopathy, majorly drives this growth. For instance, according to the PCR online, CVD continues to be the primary cause of death for both men and women worldwide. As of 2023, the global population is 8 billion, with approximately 620 million individuals living with heart and circulatory diseases. Each year, approximately 60 million people worldwide develop heart or circulatory diseases.

Furthermore, the increasing prevalence of hypertrophic cardiomyopathy (HCM)is one of the major factors contributing to the growth of the market for heart transplantation therapeutics. It is considered the most common inherited cardiomyopathy worldwide. As per the Cleveland Clinic[, the prevalence of HCM is estimated to affect approximately 1 in 500 individuals worldwide. This condition can lead to various complications, including arrhythmias, heart failure, and sudden cardiac death.Apart from hypertrophic cardiomyopathy, other genetic types of cardiomyopathies impact the market growth effectively. These include dilated cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dilated cardiomyopathy is more prevalent than HCM, affecting about 1 in 2,000 to 2,500 individuals.

The growing efforts to raise awareness about organ donation and transplantation have led to more individuals consenting to donate their organs after death. For instance, in May 2023, the Minister for Health, Stephen Donnelly, launched Organ Donor Awareness Week 2023, focusing on the progress made in organ donation and transplantation services in Ireland. In his speech, he highlighted the system's recovery from the impact of COVID-19, with 250 transplants performed in the previous year and a remarkable start to 2023 with 81 transplants in the first quarter. The Minister expressed gratitude to all involved in the process, including transplant centers, ICU staff, organ donor nurse managers, and Organ Donation and Transplant Ireland. This has helped alleviate the shortage of donor hearts available for transplantation, thereby supporting the growth of the heart transplantation therapeutics market.

Moreover, the rising geriatric population worldwide is a common factor but significantly boosts market growth. The prevalence of age-related cardiovascular conditions that may necessitate heart transplantation is on the rise. Older individuals are more likely to develop heart failure or other cardiac issues that could benefit from heart transplant therapy, thereby driving the market growth.According to the National Center for Health Statistics, in 2020, 6.3% of adults aged 18 years and over had been diagnosed with heart disease in the U.S. This estimate is based on household interviews of a sample of the civilian, noninstitutionalized U.S. population.

In 2023, findings from the Institute for Health Metrics and Evaluation study on the global burden of cardiovascular diseases and risks for 1990-2022 revealed significant insights.

  • Age-standardized cardiovascular disease (CVD) mortality rates varied regionally, ranging from 73.6 per 100,000 in High-income Asia Pacific to 432.3 per 100,000 in Eastern Europe in 2022.
  • Global CVD mortality significantly decreased by 34.9% from 1990 to 2022.
  • Leading Causes of Disability-Adjusted Life Years (DALYs): ischemic heart disease emerged as the leading global cause with age-standardized DALYs at 2,275.9 per 100,000. Intracerebral hemorrhage and ischemic stroke followed closely as prominent CVD causes for age-standardized DALYs.
  • Age-standardized CVD Prevalence: Varied globally, with rates ranging from 5,881.0 per 100,000 in South Asia to 11,342.6 per 100,000 in Central Asia.
  • Leading Risk Factor: High systolic blood pressure accounted for the largest number of attributable age-standardized CVD DALYs at 2,564.9 per 100,000 globally.
  • Significant Changes in Risk Factors (1990 to 2022): Household air pollution from solid fuels experienced the most substantial change, with a 65.1% decrease in attributable age-standardized DALYs.

Government initiatives aimed at improving organ donation rates, funding research in transplant medicine, and streamlining regulatory processes for organ transplantation have also played a role in driving the heart transplantation therapeutics market forward. These supportive measures create a conducive environment for advancements in this field.In January 2024, the International Society for Heart and Lung Transplantation (ISHLT) disclosed that it has allocated over USD 400,000 in funding to support research endeavors. It aims to enhance the care of patients with advanced heart and lung diseases. These grants were made possible through the financial backing of the ISHLT Foundation. Notably, these grants represent the second round of funding for the 2023 ISHLT grant cycles.

Global Heart Transplantation Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global heart transplantation therapeutics market report based on drug type, distribution channel, and region:

  • Drug Type Outlook (Revenue, USD Million, 2018 - 2030¬)
  • Immunosuppressants
  • Anti-infectives
  • Analgesics
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Region Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Drug Type
    • 1.1.2. Distribution Channel
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug type outlook
    • 2.2.2. Distribution channel outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Heart Transplantation Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Heart Transplantation Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Heart Transplantation Therapeutics Market: Drug Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Heart Transplantation Therapeutics Market: Drug Type Movement Analysis
  • 4.3. Heart Transplantation Therapeutics Market by Drug Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Immunosuppressants
    • 4.5.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Anti-infectives
    • 4.6.1. Anti-infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Analgesics
    • 4.7.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Heart Transplantation Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Heart Transplantation Therapeutics Market: Distribution Channel Movement Analysis
  • 5.3. Heart Transplantation Therapeutics Market by Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Retail Pharmacies
    • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Online pharmacies
    • 5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Heart Transplantation Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Heart Transplantation Therapeutics Market Movement Analysis
  • 6.3. Heart Transplantation Therapeutics Market: Regional Estimates & Trend Analysis by Technology & End use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. Mexico Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Europe
    • 6.5.6. Europe Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. UK
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. UK Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Germany
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement scenario
      • 6.5.8.5. Germany Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. France
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement scenario
      • 6.5.9.5. France Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Italy
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Competitive Scenario
      • 6.5.10.3. Regulatory Framework
      • 6.5.10.4. Reimbursement scenario
      • 6.5.10.5. Italy Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.11. Spain
      • 6.5.11.1. Key Country Dynamics
      • 6.5.11.2. Competitive Scenario
      • 6.5.11.3. Regulatory Framework
      • 6.5.11.4. Reimbursement scenario
      • 6.5.11.5. Spain Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.12. Denmark
      • 6.5.12.1. Key Country Dynamics
      • 6.5.12.2. Competitive Scenario
      • 6.5.12.3. Regulatory Framework
      • 6.5.12.4. Reimbursement scenario
      • 6.5.12.5. Denmark Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.13. Sweden
      • 6.5.13.1. Key Country Dynamics
      • 6.5.13.2. Competitive Scenario
      • 6.5.13.3. Regulatory Framework
      • 6.5.13.4. Reimbursement scenario
      • 6.5.13.5. Sweden Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.14. Norway
      • 6.5.14.1. Key Country Dynamics
      • 6.5.14.2. Competitive Scenario
      • 6.5.14.3. Regulatory Framework
      • 6.5.14.4. Reimbursement scenario
      • 6.5.14.5. Norway Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Japan Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. China Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. India Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. South Korea Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Australia Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Thailand Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Brazil Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Argentina Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. South Africa Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Saudi Arabia Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. UAE Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Kuwait Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Astellas Pharma Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Biocon Ltd.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Dr Reddys Laboratories Ltd.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Endo International Plc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. GlaxoSmithKline Plc
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Glenmark Pharmaceuticals Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Intas Pharmaceuticals Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Jubilant Pharmova Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. LEO Pharma AS
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Lupin Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 4. Global heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 5. North America heart transplantation therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 7. North America heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8. U.S. heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 9. U.S. heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10. Mexico heart transplantation Therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 11. Mexico heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12. Canada heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 13. Canada heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14. Europe heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 16. Europe Heart Transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17. UK heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 18. UK heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19. Germany heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 20. Germany heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21. France heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 22. France heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23. Italy heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 24. Italy heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25. Spain heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 26. Spain heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27. Norway heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 28. Norway heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29. Sweden heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 30. Sweden heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31. Denmark heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 32. Denmark heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36. Japan heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 37. Japan heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38. China heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 39. China heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40. India heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 41. India heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42. Australia heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 43. Australia heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44. South Korea heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 45. South Korea heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46. Thailand heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 47. Thailand heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48. Latin America heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 50. Latin America heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51. Brazil heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 52. Brazil heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53. Argentina heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 54. Argentina heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58. South Africa heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 59. South Africa heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62. UAE heart transplantation Therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 63. UAE heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64. Kuwait heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 65. Kuwait heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Heart Transplantation Therapeutics market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Heart transplantation therapeutics market, drug type outlook key takeaways (USD Million)
  • Fig. 12 Heart transplantation therapeutics market: drug type movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Immunosuppressants market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Anti-infectives market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Analgesics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Heart transplantation therapeutics market, distribution channel outlook key takeaways (USD Million)
  • Fig. 18 Heart transplantation therapeutics market: distribution channel movement analysis 2023 & 2030 (USD Million)
  • Fig. 19 Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Online pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Heart transplantation therapeutics market: Regional key takeaways (USD Million)
  • Fig. 23 Heart transplantation therapeutics market: regional outlook, 2023 & 2030, USD Million
  • Fig. 24 North America heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Canada heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Spain heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Sweden heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Norway heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 China heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 South Korea heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Middle East and Africa heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UAE heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 List of key emerging company's/technology disruptors/innovators